Navigation Links
Mayo Clinic launches whole genome breast cancer study
Date:4/9/2012

ROCHESTER, Minn. -- The Breast Cancer Genome Guided Therapy Study (BEAUTY Project) will help physicians tailor chemotherapy to breast cancer patients based on their individual genomes and the genomes of their tumors. Mayo Clinic researchers will obtain three whole genome sequences: one from the patients' healthy cells before treatment, and two tumor genomes one before chemotherapy and one after. Patients will be paired with mouse "avatars" that will help physicians identify the best treatment for each person.

VIDEO ALERT: Audio and video resources are available on the Mayo Clinic News Blog(http://newsblog.mayoclinic.org/2012/04/05/mayo-clinic-launches-whole-genome-breast-cancer-study/).

"What is so exciting about this study is that it has the potential to really bring individualized medicine to our patients," says Matthew Goetz, M.D., Mayo oncologist and study co-leader. "It will transform how we conduct breast cancer research and how drug therapies are delivered to women with breast cancer."

In phase one of the BEAUTY Project, researchers will study the first 200 participants to look for common mutations that allow some tumors to adapt and thrive during chemotherapy. This information will help doctors identify new drugs and treatment strategies.

Women diagnosed with "high-risk" cancers who are scheduled to receive standard chemotherapy before surgery will have their healthy genome and their breast cancer tumor cells sequenced before treatment, and then receive the commonly prescribed chemotherapy to shrink the tumor. At surgery, the residual cancer tumor cells will be sequenced again to evaluate how they have mutated and adapted to chemotherapy.

In addition, patients' tumor tissue will be kept alive by implanting cell lines in immune-compromised mice -- before and after chemotherapy. The use of these mouse "avatars'' will let researchers study the effects of chemotherapy on individual patient tumors and identify the best treatment, without risk of harm to the patient.

"Patients are pleased after definitive breast surgery to be cancer free," says Judy Boughey, M.D., a Mayo breast surgeon and study co-leader. "Unfortunately, a subset of high-risk patients still may experience recurrence, even months or years later. We designed this study to give those patients hope that our ability to decode the genome of every patient might give us new tools to treat cancer."

Oncologists, surgeons, radiologists, and genomics and cancer researchers will work together to uncover the clues to effective individualized therapies and drug discovery. The BEAUTY Project is being funded by benefactors and the Mayo Clinic Center for Individualized Medicine, in collaboration with the Mayo Clinic Cancer Center.

"We are living in an era that I never thought I'd see during my career -- when we can sequence, in real time, the entire genome of a patient and her tumor and use that information to tailor treatment to the individual patient," says Richard Weinshilboum, M.D., director of the Pharmacogenomics Program in the Mayo Clinic Center for Individualized Medicine.

Together, the whole-genome sequencing data and transplanted cell lines are used to identify the gene pathways that influence individual patients' responses to chemotherapy. Armed with this deeper understanding of the genomics of cancer, doctors will be able to optimize treatment plans for individual patients.

This approach, called pharmacogenomics, is part of an ongoing effort at Mayo Clinic to personalize medicine for every patient and will help doctors prescribe the right drug for the right patient at the right dose and time. Additional work is being done in the Center for Individualized Medicine to develop clinical decision support tools to help doctors prescribe the best medication for each patient based on the latest pharmacogenomic knowledge.

Though initially being applied to breast cancer, this approach will be used in the future to study the treatment of many other types of cancer.


'/>"/>
Contact: Robert Nellis
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Related medicine news :

1. Clinical news alert from the American Academy of Orthopaedic Surgeons
2. Clinical insight improves treatment with new lung cancer drug
3. First targeted nanomedicine to enter human clinical studies
4. Lower GI problems plague many with rheumatoid arthritis, Mayo Clinic study finds
5. Early clinical data show galeterone safe, effective against prostate cancer
6. Cleveland Clinic study shows bariatric surgery improves, reverses diabetes
7. Stephanie R. Wilson, MD, to be presented with the Joseph H. Holmes Clinical Pioneer Award
8. Mayo Clinic researchers building melanoma vaccine to combat skin cancer
9. Mayo Clinic review: Blood pressure drug effective for treating PTSD-related nightmares
10. Standardized outcome measures proposed for asthma clinical research
11. Mayo Clinic: Robotic surgery proves successful, less invasive way to treat HPV-related oral cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... , ... February 21, 2017 , ... Doctors on Liens ... directed by Dr. Kendell Mendonca , to its growing network of doctors in ... including injuries stemming from car accidents such as whiplash, back pain, neck pain, hip ...
(Date:2/21/2017)... ... 2017 , ... American Veterinarian™, the premier multimedia provider of ... first bi-monthly issue of 2017 in February. The inaugural issue will offer expert ... , In making the announcement, American Veterinarian™ Publisher Chris Hennessy said, “We ...
(Date:2/21/2017)... ... February 21, 2017 , ... One ... untreated despite the medical, mental health, and financial consequences of inaction. On March ... take action if they have concerns about their hearing. , Effective treatment in ...
(Date:2/20/2017)... ... February 20, 2017 , ... MRI screening improves early diagnosis of ... from Germany published online in the journal Radiology . , MRI has ... than mammography and ultrasound. Currently, guidelines reserve breast MRI screening for women who have ...
(Date:2/20/2017)... FL (PRWEB) , ... February 20, 2017 , ... ... beth[at]orbitahealth[dot]com, +1 (414) 213-8818 , Orbita, Inc., a leading provider of innovative software ... solution for increasing patient engagement and optimizing care journey management for home healthcare. ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... 21, 2017 Medical Oxygen Concentrators Market: ... http://www.reportlinker.com/p04711311-summary/view-report.html Medical oxygen concentrators are used ... diseases. Patients having low level of oxygen in ... Oxygen concentrators are to be used only with ... Medical oxygen concentrators work either on rechargeable lithium ...
(Date:2/21/2017)... YORK , Feb. 21, 2017   ... focused on the development of innovative immuno-oncology cancer ... statistically significant data from its Phase 2 trial ... for the treatment of non-small cell lung cancer ... presentation at this year,s ASCO-SITC Clinical Immuno-Oncology Symposium ...
(Date:2/21/2017)... 21, 2017 Centurion Medical Products, a ... care, is making a major stride in emergency ... its IRIG-8™Wound Irrigation System . ... deliver copious volumes of irrigation solution to acute ... a significant improvement to the traditional syringe with ...
Breaking Medicine Technology: